Olanzapine ODT 15mg Tablets

Manufacturer DR.REDDY'S Active Ingredient Olanzapine Orally Disintegrating Tablets(oh LAN za peen) Pronunciation oh LAN za peen
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat bipolar disorder. It is used to treat schizophrenia.It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Atypical Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Thienobenzodiazepine; Serotonin-Dopamine Antagonist (SDA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Olanzapine ODT is a medication used to treat mental health conditions like schizophrenia and bipolar disorder. It belongs to a group of medicines called 'atypical antipsychotics.' It works by helping to balance certain natural chemicals in the brain. The ODT (Orally Disintegrating Tablet) form dissolves quickly on your tongue without water.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Be cautious in hot weather or when engaging in physical activity, and drink plenty of fluids to prevent dehydration.
You can take this medication with or without food. If it causes stomach upset, take it with food to help minimize this side effect.

It's essential to continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Special Instructions for Taking Your Medication

When opening the foil packaging, do not push the tablet out. Instead, use dry hands to remove it from the foil.
Place the tablet on your tongue and allow it to dissolve. You don't need to drink water with it. Do not swallow the tablet whole, and avoid chewing, breaking, or crushing it.
If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light and moisture. Avoid storing it in a bathroom.
Use the oral-disintegrating tablet immediately after opening the pouch. Discard any unused portion of the pouch.
Keep all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
If it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once a day.
  • Do not chew or crush the ODT tablet; allow it to dissolve on your tongue.
  • Avoid alcohol and other sedating medications, as they can increase drowsiness.
  • Be aware of potential weight gain and metabolic changes; maintain a healthy diet and exercise routine.
  • Stand up slowly to avoid dizziness from orthostatic hypotension.
  • Avoid overheating and dehydration, as olanzapine can impair body temperature regulation.
  • Do not stop taking the medication suddenly without consulting your doctor, as this can lead to withdrawal symptoms or worsening of your condition.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Schizophrenia: Initial 5-10 mg once daily; target 10-15 mg/day. Bipolar I Disorder (manic/mixed episodes): Monotherapy initial 10-15 mg once daily; Adjunctive initial 10 mg once daily. Bipolar I Disorder (maintenance): 5-20 mg once daily.
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

Schizophrenia: Initial 5-10 mg once daily, target 10-15 mg/day. Max 20 mg/day.
Bipolar I Disorder (manic/mixed episodes): Monotherapy: Initial 10-15 mg once daily. Adjunctive to lithium or valproate: Initial 10 mg once daily. Max 20 mg/day.
Bipolar I Disorder (maintenance): 5-20 mg once daily.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Schizophrenia (13-17 years): Initial 2.5-5 mg once daily, target 10 mg/day. Max 20 mg/day. Bipolar I Disorder (13-17 years): Initial 2.5-5 mg once daily, target 10 mg/day. Max 20 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment generally required.
Moderate: No dosage adjustment generally required.
Severe: No dosage adjustment generally required, but caution advised.
Dialysis: Not significantly removed by dialysis; no specific adjustment, but monitor for adverse effects.

Hepatic Impairment:

Mild: No specific adjustment, but caution.
Moderate: Consider lower initial dose (e.g., 5 mg/day) and slower titration.
Severe: Not recommended due to lack of data; use with extreme caution if necessary, with lower initial dose and careful monitoring.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Olanzapine is an atypical antipsychotic that exhibits antagonism at multiple receptors, including dopamine D1, D2, D3, D4, D5, serotonin 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT6, muscarinic M1-M5, alpha1-adrenergic, and histamine H1 receptors. Its antipsychotic activity is thought to be mediated through a combination of dopamine D2 and serotonin 5-HT2A antagonism.
📊

Pharmacokinetics

Absorption:

Bioavailability: 60%
Tmax: 5-8 hours
FoodEffect: Not significantly affected by food; ODT formulation dissolves rapidly on the tongue, but absorption profile is similar to conventional tablets.

Distribution:

Vd: 1000 L
ProteinBinding: 93% (primarily to albumin and alpha1-acid glycoprotein)
CnssPenetration: Yes

Elimination:

HalfLife: 21-54 hours (average 33 hours)
Clearance: Not available (highly variable)
ExcretionRoute: Urine (57%), Feces (30%)
Unchanged: Approximately 7% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Within hours for sedation/agitation; weeks for full antipsychotic effect.
PeakEffect: Not precisely defined for therapeutic effect; peak plasma concentration at 5-8 hours.
DurationOfAction: 24 hours (allows once-daily dosing)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Olanzapine is not approved for the treatment of patients with dementia-related psychosis. Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) has also been observed in clinical trials of elderly patients with dementia-related psychosis treated with olanzapine.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Neurological symptoms, such as:
+ Trouble controlling body movements
+ Twitching
+ Change in balance
+ Trouble swallowing or speaking
Mental, mood, or behavior changes that are new or worsening, including:
+ Thoughts of hurting yourself or suicide
Severe dizziness or passing out
Abnormal heartbeat (fast or slow)
Inability to sweat during activities or in warm temperatures
Seizures
Drooling
Changes in eyesight
Memory problems or loss
Chest pain
Swelling
Burning, numbness, or tingling sensations that are not normal
Trouble passing urine
Hormonal changes, including:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction
+ Menstrual changes
Swollen glands
Neuroleptic malignant syndrome (NMS), a rare but potentially deadly condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell counts, which can increase the risk of infection; if you have a history of low white blood cell counts, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle problem, which may cause:
+ Trouble controlling body movements
+ Problems with your tongue, face, mouth, or jaw, such as:
- Tongue sticking out
- Puffing cheeks
- Mouth puckering
- Chewing

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it is essential to be aware of the following potential side effects:

Feeling dizzy, sleepy, tired, or weak
Restlessness
Shakiness
Headache
Constipation
Dry mouth
Upset stomach
Weight gain
Increased appetite
Back pain
Joint pain
Trouble sleeping

If you experience any of these side effects or any other symptoms that concern you, contact your doctor or seek medical attention. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide guidance on managing side effects and offer medical advice.
🚨

Seek Immediate Medical Attention If You Experience:

  • Uncontrolled movements of the face, tongue, or other body parts (tardive dyskinesia)
  • High fever, stiff muscles, confusion, sweating, fast or irregular heartbeat (Neuroleptic Malignant Syndrome - NMS)
  • Signs of high blood sugar: increased thirst, increased urination, increased hunger, weakness
  • Signs of allergic reaction: rash, hives, swelling of face/lips/tongue, difficulty breathing
  • Severe dizziness or fainting, especially when standing up
  • Seizures
  • Sore throat, fever, or other signs of infection (agranulocytosis is rare but serious)
  • Difficulty swallowing
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.

To ensure your safety, it is crucial to verify that this medication can be taken with all your current medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Information About Your Medication

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require you to be alert. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be cautious when climbing stairs.

Potential Health Risks
Medications like this one have been associated with increased risks of high blood sugar or diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease. To monitor your health, follow your doctor's instructions for checking your blood sugar levels and undergoing blood work and other laboratory tests.

Substance Interactions
Avoid consuming alcohol while taking this medication. Before using marijuana, other forms of cannabis, or prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor.

Common Side Effects
This medication may cause dizziness, drowsiness, and impaired balance, increasing the risk of falls and related injuries, such as broken bones. Be cautious to prevent accidents.

Severe Allergic Reaction
In rare cases, a severe and potentially life-threatening reaction may occur, characterized by symptoms like fever, rash, swollen glands, and problems with organs such as the liver, kidney, blood, heart, muscles and joints, or lungs. If you have concerns, discuss them with your doctor.

Special Considerations for Older Adults
Older adults with dementia who take medications like this one have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Pediatric Use
When administering this medication to children, use caution, as the risk of certain side effects may be higher in this population.

Reproductive Health
This medication may affect fertility, but this effect is reversible when the medication is discontinued. If you have questions or concerns, consult with your doctor.

Pregnancy and Breastfeeding
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. You will need to discuss the benefits and risks of this medication for both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Slurred speech
  • Agitation
  • Tachycardia (fast heart rate)
  • Extrapyramidal symptoms (e.g., tremors, muscle stiffness)
  • Hypotension (low blood pressure)
  • Respiratory depression
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222.

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines, opioids): Increased risk of sedation, respiratory depression, hypotension.
  • CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May increase olanzapine plasma concentrations, requiring dose reduction.
  • CYP1A2 inducers (e.g., carbamazepine, rifampin, omeprazole, smoking): May decrease olanzapine plasma concentrations, requiring dose increase.
  • Anticholinergic agents: Potentiation of anticholinergic effects (e.g., severe constipation, urinary retention, heat intolerance).
🟡

Moderate Interactions

  • Antihypertensive agents: Increased risk of orthostatic hypotension.
  • Dopamine agonists (e.g., bromocriptine, levodopa): Olanzapine may antagonize their effects.
  • Drugs that prolong QT interval: Additive risk of QT prolongation (use with caution).
đŸŸĸ

Minor Interactions

  • Lithium or Valproate: No significant pharmacokinetic interaction, but monitor for additive CNS effects.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Weight/BMI

Rationale: Risk of significant weight gain.

Timing: Before initiation

Fasting Plasma Glucose (FPG)

Rationale: Risk of hyperglycemia and diabetes.

Timing: Before initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Blood Pressure

Rationale: Risk of orthostatic hypotension.

Timing: Before initiation

Personal/Family History of Diabetes/Dyslipidemia

Rationale: Identifies patients at higher metabolic risk.

Timing: Before initiation

Abnormal Involuntary Movement Scale (AIMS)

Rationale: Baseline for monitoring tardive dyskinesia.

Timing: Before initiation

ECG

Rationale: Consider if patient has pre-existing cardiac disease or risk factors for QT prolongation.

Timing: Before initiation (if indicated)

📊

Routine Monitoring

Weight/BMI

Frequency: Monthly for first few months, then quarterly

Target: Maintain healthy BMI

Action Threshold: Significant weight gain (e.g., >7% baseline) warrants intervention.

Fasting Plasma Glucose (FPG)

Frequency: At 3 months, then annually (or more frequently if risk factors present)

Target: <100 mg/dL

Action Threshold: >125 mg/dL (diabetes), 100-125 mg/dL (pre-diabetes) warrants intervention/referral.

Lipid Panel (Fasting)

Frequency: At 3 months, then annually (or more frequently if risk factors present)

Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL

Action Threshold: Abnormal values warrant intervention/referral.

Blood Pressure

Frequency: Regularly (e.g., monthly for first few months, then quarterly)

Target: Normal BP

Action Threshold: Significant orthostatic drop or sustained hypertension warrants intervention.

Abnormal Involuntary Movement Scale (AIMS)

Frequency: Every 6-12 months

Target: No abnormal movements

Action Threshold: Emergence or worsening of abnormal movements warrants assessment for tardive dyskinesia.

đŸ‘ī¸

Symptom Monitoring

  • Sedation/Drowsiness
  • Dizziness/Orthostatic Hypotension
  • Extrapyramidal Symptoms (EPS) including akathisia, dystonia, parkinsonism
  • Tardive Dyskinesia (involuntary movements, especially of face and tongue)
  • Neuroleptic Malignant Syndrome (NMS) - fever, muscle rigidity, altered mental status, autonomic instability
  • Anticholinergic effects (e.g., dry mouth, constipation, blurred vision, urinary retention)
  • Signs of hyperglycemia (e.g., polyuria, polydipsia, polyphagia, weakness)
  • Signs of dyslipidemia
  • Seizures
  • Changes in mental status or behavior

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased major congenital malformations.
Second Trimester: Limited data.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder).
🤱

Lactation

Olanzapine is excreted into human breast milk. Weigh the benefits of breastfeeding against the potential risks to the infant. Monitor breastfed infants for sedation, irritability, poor feeding, and developmental milestones.

Infant Risk: Low to moderate risk (L3). Potential for sedation, poor feeding, and weight gain in the infant.
đŸ‘ļ

Pediatric Use

Approved for adolescents (13-17 years) for schizophrenia and bipolar I disorder. Not established for children younger than 13 years. Adolescents may be at higher risk for weight gain and metabolic adverse effects compared to adults.

👴

Geriatric Use

Elderly patients, especially those with dementia-related psychosis, are at increased risk of death and cerebrovascular adverse events (e.g., stroke, TIA) when treated with olanzapine. Olanzapine is not approved for this indication. Start with lower doses and titrate slowly due to increased sensitivity to adverse effects (e.g., orthostatic hypotension, sedation, falls).

Clinical Information

💎

Clinical Pearls

  • Olanzapine ODT should be administered immediately upon removal from the blister pack. Do not push the tablet through the foil. Peel back the foil and gently remove the tablet.
  • Place the ODT on the tongue; it will rapidly disintegrate and can be swallowed with or without liquid.
  • Significant weight gain and metabolic abnormalities (hyperglycemia, dyslipidemia) are common with olanzapine. Regular monitoring of weight, blood glucose, and lipids is crucial.
  • Risk of orthostatic hypotension, especially during initial titration. Advise patients to rise slowly.
  • Monitor for tardive dyskinesia, particularly with long-term use. Consider dose reduction or discontinuation if it develops.
  • Neuroleptic Malignant Syndrome (NMS) is a rare but potentially fatal adverse effect; discontinue olanzapine immediately if NMS is suspected.
  • Olanzapine has significant anticholinergic activity, which can lead to side effects like dry mouth, constipation, and blurred vision.
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., Aripiprazole, Quetiapine, Risperidone, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
  • First-generation antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk.
  • Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine, Lamotrigine) for bipolar disorder.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 for generic, $500-$1000+ for brand per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 for generic; Tier 3 or higher for brand, often requiring prior authorization.
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.